- Home
- Serum Institute
Poonawalla urges countries please be patient, Serum directed to prioritise India needs
Relief for SII as court rejects trademark-violation plea over ‘Covishield’
Serum Institute applies for trials of another COVID-19 vaccine
Fire in Serum Institute; Covishield facility not affected
Covishield not to be taken by people severely allergic to any of its ingredients: Serum Institute
Two districts of K’taka receive over two lakh doses of Covishield
Karnataka receives first consignment of COVID-19 vaccines
Bharat Biotech, Serum Institute pledge for smooth rollout of COVID-19 vaccines
3 more test positive for COVID-19 UK strain in K’taka: Min Sudhakar
First indigenous vaccine against pneumonia developed by Serum Institute to be launched next week
Govt must indemnify vaccine makers against all lawsuits: Adar Poonawalla
SII, Centre near agreement to supply Covishield at Rs 250 per dose: report
Poonawalla of Serum Institute among 6 named ‘Asians of the Year’ by Singapore daily
Chennai volunteer’s illness not due to COVISHIELD vaccine dose, clarifies SII
ICMR, SII complete enrolment of phase-3 clinical trials for Covishield vaccine
Serum Institute to produce additional 100 mn COVID-19 vaccine doses for India, other countries
India’s role in production of COVID-19 vaccine critical in containing pandemic: Bill Gates
Latest Additions
Entire fiscal stimulus to be funded by borrowing, revenues; not taking money from people, says FM
Nepal government, Maoist rebels formally sign peace agreement
Dy director of K’taka Mines & Geology Department suspended
K’taka COVID-19 update: 677 new cases, 427 discharges, 4 deaths on March 4
Farmers’ protest internal issue of India, says British govt